Skip to main content


Not yet reviewed

Practice areas


  1. White Collar Crime: 34%
  2. Life Sciences: 33%
  3. Health Care: 33%

Attorney endorsements

No endorsements

Endorsements from fellow lawyers are an important consideration for many when selecting the right attorney. Be the first to endorse your colleague!

Are you an attorney? Endorse this lawyer

Contact info

100 Summer Street
Boston, MA, 02110


We have not found any instances of professional misconduct for this lawyer.
Avvo contributions
Legal answers
Award nameGrantorDate granted
AV Preeminent 4.9 out of 5 Peer Review RatedMartindale-Hubbell2014
Recommended attorney for Healthcare: Life SciencesThe Legal 5002013
Massachusetts Super Lawyers – Rising StarsMassachusetts Super Lawyers2007
Massachusetts Super Lawyers – Rising StarsMassachusetts Super Lawyers2005
Work experience
TitleCompany nameDuration
Partner and Deputy Practice Group LeaderNixon Peabody LLP2007 - Present
Senior CounselHolland & Knight2005 - 2007
AssociateRuberto, Israel & Weiner2003 - 2005
AssociateGoulston & Storrs1997 - 2003
Staff AttorneyGulfcoast Legal Services, Inc.1993 - 1996
Association namePosition nameDuration
Boston Bar Association, Summer Jobs Steering CommitteeMember2012 - Present
Brookline Youth HockeyTreasurer/Secretary and Board Member2012 - Present
American Bar Association, Criminal Justice Section, Health Care Fraud SubcommitteeCo-chair2012 - Present
Dana-Farber Leadership CouncilMember, Past Co-chair of Jimmy Fund Marathon Walk Committee2004 - Present
Boston Bar Association, Criminal Law Section, Public Policy SubcommitteeMember2009 - 2010
Families for Depression AwarenessSecretary and Board Member2004 - 2007
American Bar Association, Individual Rights and Responsibilities Section, Public Schools CommitteeRegional Co-chair1996 - 1998
Legal cases
Case nameOutcome
Confidential clientOngoing
Confidential clientOngoing
Confidential clientOngoing
See all legal cases 
Publication nameTitleDate
Portfolio Media (Law360)Life Sciences Cases to Watch in 20132013
Portfolio Media (Law360)Life Sciences Regulation to Watch in 20132013
Client AlertCMS Proposes $9.9 Million Reward for Medicare Fraud Whistleblowers2013
Client AlertOIG issues revised self-disclosure protocol2013
Portfolio Media (Law360)7 Tips For Avoiding False Claims Act Whistleblower Suits2012
Regulatory Affairs PharmaCorporate Integrity Agreements and New Trends in U.S. Enforcement Activities2011
Pharmaceutical ExecutiveU.S. Anti-Corruption Regulation Risks2010
American LawyerPro Bono 2010: The High Price of Life2010
School nameMajorDegreeGraduated
Boston College Law SchoolLawJD - Juris Doctor1993
University of Massachusetts, AmherstHistory/Political ScienceBA - Bachelor of Arts1990
Speaking engagements
Conference nameTitleDate
Health Care ForumDemonstrating Compliance Program Effectiveness2013
Health Care Check-up Webinar SeriesWebinar: Shedding Light on the Sunshine Act Final Rule: Implications for Health Care Providers2013
Strategies for In-House Counsel to Meet Corporate Obligations and Avoid Individual LiabilityResponding to Government Investigations: Legal and Ethical Considerations2012
Nixon Peabody EventsWebinar: Recent Developments in the Regulation of2012
Nixon Peabody EventsWebinar: The First Amendment and Off-Label Promotion: Understanding the Implications of U.S. v. Caronia2012
Health & Hospital Law: MCLE BasicsPlus!®Massachusetts Gift Ban and Physician Payment Disclosure2012
Pharmaceutical Pricing LitigationMitigating Risk in Best Price Litigation over Bundling and Price Reporting Resulting from Uncertainty and CMS Guidance2011
Update on Fraud & Abuse: Critical Components for Your Hospital's Corporate Compliance ProgramHealth Care Reform and Fraud and Abuse Prevention and Enforcement2010
Nixon Peabody EventsWebinar Recording: The Foreign Corrupt Practices Act (FCPA): Spotlight on the Pharmaceutical and Medical Device Industries One Year After the Warning2010
NH-VT HFMA Chapter’s 2nd Annual Healthcare Payment Reform SymposiumLegal & Compliance Issues Related to Healthcare Reform2010
FDA EnforcementDefining FDA’s Civil Enforcement Powers2010
Internal Investigations for the Drug & Device IndustriesPreserving Privilege in Internal Investigations2008
CBI's 3rd Forum on Clinical Trial Registries and Results DatabasesHow Should the Bio/Pharmaceutical and Medical Device Industries Respond to the Evolving Regulatory Framework for Clinical Trial Registries and Results Databases?2008
7th National Forum on Reducing Legal Risks in the Sale and Marketing of Medical DevicesLimiting Liability Through Effective Training, Monitoring and Controlling of the Sales Force2008
6th Annual Corporate Counsel Forum on Advertising & Promotions for the Pharmaceutical IndustryLimiting Promotional Missteps Through Effective MSL Training2008